Telangiectasis Global Clinical Trials Review, H2, 2016

GlobalData
42 Pages - GLDATA56901

$2,500.00

Summary

GlobalData's clinical trial report, “Telangiectasis Global Clinical Trials Review, H2, 2016" provides an overview of Telangiectasis clinical trials scenario. This report provides top line data relating to the clinical trials on Telangiectasis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Companies Mentioned

F. Hoffmann-La Roche Ltd.
Novartis AG
Nestle S.A.
Foamix Pharmaceuticals Ltd.
Ellipse A/S
Celgene Corporation

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Report Guidance 4
Clinical Trials by Region 5
Clinical Trials and Average Enrollment by Country 6
Top Countries Contributing to Clinical Trials in Europe 8
Top Countries Contributing to Clinical Trials in North America 9
Top Countries Contributing to Clinical Trials in Middle East and Africa 10
Top Countries Contributing to Clinical Trials in Central and South America 11
Clinical Trials by G7 Countries: Proportion of Telangiectasis to Cardiovascular Clinical Trials 12
Clinical Trials by Phase in G7 Countries 13
Clinical Trials in G7 Countries by Trial Status 14
Clinical Trials by E7 Countries: Proportion of Telangiectasis to Cardiovascular Clinical Trials 15
Clinical Trials by Phase in E7 Countries 16
Clinical Trials in E7 Countries by Trial Status 17
Clinical Trials by Phase 18
In Progress Trials by Phase 19
Clinical Trials by Trial Status 20
Clinical Trials by End Point Status 21
Subjects Recruited Over a Period of Time 22
Clinical Trials by Sponsor Type 23
Prominent Sponsors 24
Top Companies Participating in Telangiectasis Therapeutics Clinical Trials 25
Prominent Drugs 26
Clinical Trial Profile Snapshots 27
Appendix 39
Abbreviations 39
Definitions 39
Research Methodology 40
Secondary Research 40
About GlobalData 41
Contact Us 41
Disclaimer 41
Source 42

List of Tables
Telangiectasis Therapeutics, Global, Clinical Trials by Region, 2016* 5
Telangiectasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6
Telangiectasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 7
Telangiectasis Therapeutics Clinical Trials, Europe, Top Countries, 2016* 8
Telangiectasis Therapeutics Clinical Trials, North America, Top Countries, 2016* 9
Telangiectasis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 10
Telangiectasis Therapeutics Clinical Trials, Central and South America, Top Countries, 2016* 11
Proportion of Telangiectasis to Cardiovascular Clinical Trials, G7 Countries (%), 2016* 12
Telangiectasis Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 13
Telangiectasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 14
Proportion of Telangiectasis to Cardiovascular Clinical Trials, E7 Countries (%), 2016* 15
Telangiectasis Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 16
Telangiectasis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 17
Telangiectasis Therapeutics, Global, Clinical Trials by Phase, 2016* 18
Telangiectasis Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 19
Telangiectasis Therapeutics, Global, Clinical Trials by Trial Status, 2016* 20
Telangiectasis Therapeutics Clinical Trials, Global, by End Point Status, 2016* 21
Telangiectasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 22
Telangiectasis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 23
Telangiectasis Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 24
Telangiectasis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 25
Telangiectasis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 26

List of Figures
Telangiectasis Therapeutics, Global, Clinical Trials by Region (%), 2016* 5
Telangiectasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6
Telangiectasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 7
Telangiectasis Therapeutics Clinical Trials, Europe, Top Countries (%), 2016* 8
Telangiectasis Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 9
Proportion of Telangiectasis to Cardiovascular Clinical Trials, G7 Countries (%), 2016* 12
Telangiectasis Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 13
Telangiectasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 14
Proportion of Telangiectasis to Cardiovascular Clinical Trials, E7 Countries (%), 2016* 15
Telangiectasis Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 16
Telangiectasis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 17
Telangiectasis Therapeutics, Global, Clinical Trials by Phase (%), 2016* 18
Telangiectasis Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 19
Telangiectasis Therapeutics, Global, Clinical Trials by Trial Status, 2016* 20
Telangiectasis Therapeutics Clinical Trials, Global, by End Point Status, 2016* 21
Telangiectasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 22
Telangiectasis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 23
Telangiectasis Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 24
Telangiectasis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 25
Telangiectasis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 26
GlobalData Methodology 40

Local PDF $2,500.00
Global PDF $7,500.00

$2,500.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

Custom Research

[email protected]
+1 212 564 2838

Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838